Consequently, this promotes CD8+ T cell infiltration, activation, and effector function in the TME while suppressing tumor growth via interferon-α/β receptor (IFNAR) signaling—providing a novel strategy to boost immunotherapy response 95. This evidence concerns the gene CD8A and neoplasm.